首页> 美国卫生研究院文献>Vascular Health and Risk Management >Inhaled insulin: overview of a novel route of insulin administration
【2h】

Inhaled insulin: overview of a novel route of insulin administration

机译:吸入胰岛素:胰岛素给药新途径的概述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diabetes is a chronic disease characterized by inadequate insulin secretion with resulting hyperglycemia. Diabetes complications include both microvascular and macrovascular disease, both of which are affected by optimal diabetes control. Many individuals with diabetes rely on subcutaneous insulin administration by injection or continuous infusion to control glucose levels. Novel routes of insulin administration are an area of interest in the diabetes field, given that insulin injection therapy is burdensome for many patients. This review will discuss pulmonary delivery of insulin via inhalation. The safety of inhaled insulin as well as the efficacy in comparison to subcutaneous insulin in the various populations with diabetes are covered. In addition, the experience and pitfalls that face the development and marketing of inhaled insulin are discussed.
机译:糖尿病是一种慢性疾病,其特征在于胰岛素分泌不足导致高血糖症。糖尿病并发症包括微血管和大血管疾病,两者均受最佳糖尿病控制的影响。许多糖尿病患者依靠注射或连续输注皮下注射胰岛素来控制血糖水平。鉴于胰岛素注射疗法对许多患者来说是沉重的负担,因此新的胰岛素给药途径是糖尿病领域的关注领域。这篇综述将讨论通过吸入肺部输送胰岛素。涵盖了在各种糖尿病人群中吸入胰岛素的安全性以及与皮下胰岛素相比的功效。此外,还讨论了吸入式胰岛素的开发和销售面临的经验和陷阱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号